×
Entrez Id:
4301
Gene Symbol:
AFDN
AFDN
0.010
Biomarker
disease
BEFREE
MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia .
24695851
2014
MIR486-1
0.010
Biomarker
disease
BEFREE
MicroRNA-486 -5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome.
25533034
2015
×
Entrez Id:
54790
Gene Symbol:
TET2
TET2
0.010
Biomarker
disease
BEFREE
TET2 enzymatically converts 5-methylcytosine to 5-hydroxymethylcytosine as well as other covalently modified cytosines and its mutations are common in myeloid leukemia .
25972343
2015
×
Entrez Id:
406931
Gene Symbol:
MIR139
MIR139
0.010
Biomarker
disease
BEFREE
miR-139 -5p controls translation in myeloid leukemia through EIF4G2.
26165837
2016
×
Entrez Id:
7299
Gene Symbol:
TYR
TYR
0.010
Biomarker
disease
BEFREE
ATN -224 may be beneficial for myeloid leukemia therapy.
26241492
2015
×
Entrez Id:
124540
Gene Symbol:
MSI2
MSI2
0.030
Biomarker
disease
BEFREE
Musashi 2 (MSI2), a RNA-binding protein, was proposed to be a potent oncogene playing key roles in myeloid leukemia and gastrointestinal malignancies.
27721018
2017
×
Entrez Id:
7543
Gene Symbol:
ZFX
ZFX
0.010
Biomarker
disease
BEFREE
Zinc finger protein X-linked (ZFX ) is a key regulator of both embryonic stem cells (ESCs) and hematopoietic stem cells (HSCs), which is required for both Notch intracellular domain (NotchIC)-induced acute T-cell leukemia and MLL-AF9-induced myeloid leukemia in mouse models.
27797721
2016
×
Entrez Id:
943
Gene Symbol:
TNFRSF8
TNFRSF8
0.020
AlteredExpression
disease
BEFREE
CD30 Expression Is Rare in Myeloid Leukemia Cutis : A Study of 55 Cases and Implications for Routine Diagnostic Algorithms.
27893466
2017
×
Entrez Id:
861
Gene Symbol:
RUNX1
RUNX1
0.100
GeneticVariation
disease
BEFREE
RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia , FPDMM).
28637620
2017
×
Entrez Id:
3586
Gene Symbol:
IL10
IL10
0.010
Biomarker
disease
BEFREE
IL-10 -Engineered Human CD4<sup>+</sup> Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism.
28807569
2017
×
Entrez Id:
861
Gene Symbol:
RUNX1
RUNX1
0.100
GeneticVariation
disease
BEFREE
RUNX1 translocations result in the development of myeloid leukemias .
28926105
2018
×
Entrez Id:
4602
Gene Symbol:
MYB
MYB
0.020
Biomarker
disease
BEFREE
MYB -driven transcriptional coactivation with CREB-binding protein (CBP)/P300 is required for acute lymphoblastic and myeloid leukemias , including refractory MLL-rearranged leukemias.
29317678
2018
×
Entrez Id:
2146
Gene Symbol:
EZH2
EZH2
0.010
Biomarker
disease
BEFREE
Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic Progenitors.
29438697
2018
×
Entrez Id:
23326
Gene Symbol:
USP22
USP22
0.010
Biomarker
disease
BEFREE
USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism.
29844011
2018
×
Entrez Id:
406935
Gene Symbol:
MIR143
MIR143
0.010
Biomarker
disease
BEFREE
MiR-143 regulates proliferation and apoptosis of myelocytic leukemia cell HL-60 via modulating ERK1.
29917183
2018
×
Entrez Id:
57447
Gene Symbol:
NDRG2
NDRG2
0.010
Biomarker
disease
BEFREE
NDRG2 Sensitizes Myeloid Leukemia to Arsenic Trioxide via GSK3β-NDRG2-PP2A Complex Formation.
31121982
2019
×
Entrez Id:
4211
Gene Symbol:
MEIS1
MEIS1
0.050
GeneticVariation
disease
BEFREE
Meis1 locus was isolated as a common site of viral integration involved in myeloid leukemia in BXH-2 mice.
9049632
1997
×
Entrez Id:
862
Gene Symbol:
RUNX1T1
RUNX1T1
0.100
Biomarker
disease
BEFREE
MTG8 is a counterpart gene of AML1 in acute myeloid leukemia with t(8:21) translocation.
9209371
1997
×
Entrez Id:
861
Gene Symbol:
RUNX1
RUNX1
0.100
Biomarker
disease
BEFREE
AML1 , a gene on chromosome 21 encoding a transcription factor, is disrupted in the (8;21)(q22;q22) and (3;21)(q26;q22) chromosomal translocations associated with myelogenous leukemias ; as a result, chimeric proteins AML1/ETO(MTG8) and AML1/Evi-1 are generated, respectively.
9473235
1998
×
Entrez Id:
861
Gene Symbol:
RUNX1
RUNX1
0.100
Biomarker
disease
BEFREE
CBFA2 forms a fusion gene with ETO and MDS1/EVI1 in translocations in myeloid leukemia and with ETV6(TEL) in the t(12;21) common in childhood pre-B acute lymphoblastic leukemia.
9763573
1998
×
Entrez Id:
2322
Gene Symbol:
FLT3
FLT3
0.080
GeneticVariation
disease
BEFREE
D324N single-nucleotide polymorphism in the FLT3 gene is associated with higher risk of myeloid leukemias .
16320249
2006
×
Entrez Id:
28951
Gene Symbol:
TRIB2
TRIB2
0.020
Biomarker
disease
BEFREE
A Trib2 -p38 axis controls myeloid leukaemia cell cycle and stress response signalling.
29670085
2018
×
Entrez Id:
84106
Gene Symbol:
PRAM1
PRAM1
0.020
AlteredExpression
disease
BEFREE
A case of acute eosinophilic granulocytic leukemia with PML-RAR alpha fusion gene expression and response to all-trans retinoic acid.
9096703
1997
×
Entrez Id:
8928
Gene Symbol:
FOXH1
FOXH1
0.010
Biomarker
disease
BEFREE
A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1 .
31068365
2019
×
Entrez Id:
3492
Gene Symbol:
IGH
IGH
0.010
GeneticVariation
disease
BEFREE
A greater incidence of complex translocations in myeloid leukemias than in lymphomas and lymphoid leukemias associated with IGH rearrangement.
8616794
1996